Balchem Corporation

As of March 31, 2026, Balchem Corp carries a market capitalization of 4.82B, placing it among publicly traded companies globally. Its enterprise value stands at 4.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Balchem Corp's next confirmed earnings release is scheduled for October 23, 2026.

As of March 31, 2026, Balchem Corp has 32.13M shares outstanding.

As of March 31, 2026, Balchem Corp trades at a trailing price-to-earnings ratio of 35.36. The price-to-sales ratio is 5.29, and the price-to-book ratio stands at 4.33.

As of March 31, 2026, Balchem Corp trades at an EV/EBITDA multiple of 21.75 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.37 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 26.54 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Balchem Corp trades at an EV/FCF ratio of 24.96, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 4.91B versus a market cap of 4.82B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Balchem Corp maintains a current ratio of 2.55, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 14.37, indicating elevated leverage, while an interest coverage ratio of 27.46 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Balchem Corp posted a return on equity (ROE) of 12.68, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 11.41 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.55, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 11.46, useful for judging operating efficiency across full business cycles. The company generates approximately 674,319.46 in revenue per employee across its workforce of 1,356.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.62 indicates how many times Balchem Corp sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Balchem Corp recorded 39.39M in income tax expense. That works out to an effective tax rate of 22.36, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 176.14M, leaving 136.75M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

These figures are as of the close on October 22, 2026. The 50-day moving average sits at 146.97, while the 200-day moving average is 144.47.

Over the twelve months ended March 31, 2026, Balchem Corp generated 914.71M in revenue and converted that into 136.75M in net income, yielding earnings per share of 4.21. EBITDA reached 225.88M, while operating income came in at 185.08M.

As of March 31, 2026, Balchem Corp holds 63.04M in cash and equivalents against 159.80M in total debt, resulting in a net debt position of 83.16M. Total book value stands at 1.11B, with working capital of 204.51M providing operational flexibility.

Balchem Corp produced 190.46M in operating cash flow over the twelve months ended March 31, 2026.

Over the twelve months ended March 31, 2026, Balchem Corp posted a gross margin of 36.27, reflecting its pricing power and cost economics. The operating margin of 20.23 and net profit margin of 14.95 provide insight into operational efficiency.

Over the twelve months ended March 31, 2026, Balchem Corp paid dividends of 0.83 per share. The dividend payout ratio of 19.48 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 3.91, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.80, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Balchem Corp shareholders.

Balchem Corp's most recent stock split took place on January 21, 2010 with a 2:3 split ratio.

As of March 31, 2026, Balchem Corp has an Altman Z-Score of 13.24, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.